Type I IFN-induced lncRNA ISR2 can enhance antiviral responses when delivered via nanoparticle systems (102), miR-146a—an immunosuppressive miRNA upregulated during HIV infection—can be inhibited by anti-miR-146a, thereby augmenting IFN-mediated T-cell activation (103). The gene discussed is IFNA1; the disease is HIV infectious disease.